-
1
-
-
0030979361
-
Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society-USA panel
-
Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA. 1997;277:1962-1969.
-
(1997)
JAMA
, vol.277
, pp. 1962-1969
-
-
Carpenter, C.C.J.1
Fischl, M.A.2
Hammer, S.M.3
-
3
-
-
16944367032
-
HIV infection induces changes in CD4 T-cell phenotype and within the CD4 T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
-
Conners M, Kovacs JA, Krevet S, et al. HIV infection induces changes in CD4 T-cell phenotype and within the CD4 T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med. 1997;3:533-540.
-
(1997)
Nat Med.
, vol.3
, pp. 533-540
-
-
Conners, M.1
Kovacs, J.A.2
Krevet, S.3
-
4
-
-
3543008381
-
Immunological reconstitution after triple combination therapy in HIV-1 infection: A composition of redistribution and proliferation
-
February 1-5, Chicago, Ill. Abstract 20
-
Miedema F, Pakker NG, Notermans DW, et al. Immunological reconstitution after triple combination therapy in HIV-1 infection: a composition of redistribution and proliferation. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1-5, 1998; Chicago, Ill. Abstract 20.
-
(1998)
Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections
-
-
Miedema, F.1
Pakker, N.G.2
Notermans, D.W.3
-
5
-
-
0345178968
-
Delayed and sustained immunologic recovery after 15 months of active antiretroviral therapy
-
February 1-5, Chicago, Ill. Abstract 163
-
Goujard C, Wallon C, Taoufik Y, Lantz O, Delfraissy JF. Delayed and sustained immunologic recovery after 15 months of active antiretroviral therapy. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1-5, 1998; Chicago, Ill. Abstract 163.
-
(1998)
Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections
-
-
Goujard, C.1
Wallon, C.2
Taoufik, Y.3
Lantz, O.4
Delfraissy, J.F.5
-
6
-
-
2642709177
-
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
-
Palella F Jr, Delany K, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
-
(1998)
N Engl J Med.
, vol.338
, pp. 853-860
-
-
Palella Jr., F.1
Delany, K.2
Moorman, A.3
-
7
-
-
17344373825
-
Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients
-
Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis. 1998;177:1080-1083.
-
(1998)
J Infect Dis.
, vol.177
, pp. 1080-1083
-
-
Tural, C.1
Romeu, J.2
Sirera, G.3
-
8
-
-
0001633495
-
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
-
Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 1996;273:1856-1862.
-
(1996)
Science
, vol.273
, pp. 1856-1862
-
-
Dean, M.1
Carrington, M.2
Winkler, C.3
-
9
-
-
0442268112
-
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
-
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337:725-733.
-
(1997)
N Engl J Med.
, vol.337
, pp. 725-733
-
-
Hammer, S.M.1
Squires, K.E.2
Hughes, M.D.3
-
10
-
-
0027510616
-
Hepatomegaly with severe steatosis in HIV-seropositive patients
-
Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS. 1993;7:379-385.
-
(1993)
AIDS
, vol.7
, pp. 379-385
-
-
Freiman, J.P.1
Helfert, K.E.2
Hamrell, M.R.3
Stein, D.S.4
-
11
-
-
0005868413
-
A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance due to HIV protease inhibitors
-
February 1-5, Chicago, Ill. Abstract 410
-
Carr A, Samaras K, Burton S, Freund J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin resistance due to HIV protease inhibitors. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections; February 1-5, 1998; Chicago, Ill. Abstract 410.
-
(1998)
Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections
-
-
Carr, A.1
Samaras, K.2
Burton, S.3
Freund, J.4
Chisholm, D.J.5
Cooper, D.A.6
-
12
-
-
17144463863
-
Severe premature coronary artery disease with protease inhibitors
-
Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328.
-
(1998)
Lancet
, vol.351
, pp. 1328
-
-
Henry, K.1
Melroe, H.2
Huebsch, J.3
-
13
-
-
0029132121
-
Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
-
Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation. 1995;92:1326-1331.
-
(1995)
Circulation
, vol.92
, pp. 1326-1331
-
-
Furberg, C.D.1
Psaty, B.M.2
Meyer, J.V.3
-
14
-
-
0013586127
-
Bi-directional inhibition of HIV-1 drug resistance selection by combination therapy with indinavir and reverse transcriptase inhibitors
-
July 7-12, Vancouver, British Columbia. Abstract Th.B.932
-
Condra JH, Holder DJ, Schleif WA. Bi-directional inhibition of HIV-1 drug resistance selection by combination therapy with indinavir and reverse transcriptase inhibitors. In: Program and abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia. Abstract Th.B.932.
-
(1996)
Program and Abstracts of the XI International Conference on AIDS
-
-
Condra, J.H.1
Holder, D.J.2
Schleif, W.A.3
-
15
-
-
0024244030
-
Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily
-
Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther. 1988;44:540-545.
-
(1988)
Clin Pharmacol Ther.
, vol.44
, pp. 540-545
-
-
Pullar, T.1
Birtwell, A.J.2
Wiles, P.G.3
Hay, A.4
Feely, M.P.5
-
16
-
-
0024343414
-
How often is medication taken as prescribed? A novel assessment technique
-
Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oullette VL. How often is medication taken as prescribed? a novel assessment technique. JAMA. 1989; 261:3273-3277.
-
(1989)
JAMA
, vol.261
, pp. 3273-3277
-
-
Cramer, J.A.1
Mattson, R.H.2
Prevey, M.L.3
Scheyer, R.D.4
Oullette, V.L.5
-
18
-
-
0018166371
-
Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen
-
Roth H, Caron H. Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen. Clin Pharmacol Ther. 1978;23:361-370.
-
(1978)
Clin Pharmacol Ther.
, vol.23
, pp. 361-370
-
-
Roth, H.1
Caron, H.2
-
20
-
-
3543030486
-
Recent experience with post-exposure prophylaxis (PEP) with combination antiretrovirals for occupational exposure (OE) to HIV
-
Steger KA, Swotinsky R, Snyder S, Craven DE. Recent experience with post-exposure prophylaxis (PEP) with combination antiretrovirals for occupational exposure (OE) to HIV. Clin Infect Dis. 1997-25:444.
-
(1997)
Clin Infect Dis.
, vol.25
, pp. 444
-
-
Steger, K.A.1
Swotinsky, R.2
Snyder, S.3
Craven, D.E.4
-
21
-
-
0008646434
-
Human immunodeficiency virus postexposure prophylaxis following occupational HIV exposure: Findings from the HIV PEP Registry
-
Wang SA, and the HIV PEP Registry Group. Human immunodeficiency virus postexposure prophylaxis following occupational HIV exposure: findings from the HIV PEP Registry. Clin Infect Dis. 1998;25:444.
-
(1998)
Clin Infect Dis.
, vol.25
, pp. 444
-
-
Wang, S.A.1
-
22
-
-
0028943992
-
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
-
Condra JH, Schleif WA, Blahy OM, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature. 1995;374:569-571.
-
(1995)
Nature
, vol.374
, pp. 569-571
-
-
Condra, J.H.1
Schleif, W.A.2
Blahy, O.M.3
-
23
-
-
3542998725
-
Increasing frequency of antiviral naive patients harboring 215-mutant HIV-1 virus during 1989-1996
-
November 3-7, Birmingham, England. Abstract OP2.4
-
Rubio A, Leal M, Pineda J, et al. Increasing frequency of antiviral naive patients harboring 215-mutant HIV-1 virus during 1989-1996. In: Program and abstracts of the Third International Conference on Drug Therapy in HIV Infection; November 3-7, 1996; Birmingham, England. Abstract OP2.4.
-
(1996)
Program and Abstracts of the Third International Conference on Drug Therapy in HIV Infection
-
-
Rubio, A.1
Leal, M.2
Pineda, J.3
-
24
-
-
0031587216
-
Gonorrhea among men who have sex with men - Selected sexually transmitted disease clinics, 1993-1996
-
Centers for Disease Control and Prevention. Gonorrhea among men who have sex with men - selected sexually transmitted disease clinics, 1993-1996. MMWR Morb Mortal Wkly Rep. 1997;46:889-892.
-
(1997)
MMWR Morb Mortal Wkly Rep.
, vol.46
, pp. 889-892
-
-
-
25
-
-
0031021203
-
Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project
-
Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis. 1997;24(suppl):S121-S130.
-
(1997)
Clin Infect Dis.
, vol.24
, Issue.SUPPL.
-
-
Cohn, D.L.1
Bustreo, F.2
Raviglione, M.C.3
-
26
-
-
0030935802
-
British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
-
BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet. 1997;349:1086-1092.
-
(1997)
Lancet
, vol.349
, pp. 1086-1092
-
-
|